PrintAs the global medical technology landscape continues to evolve, the demand for miniaturization and precision in component manufacturing has never been greater. At COMPAMED 2025 in Dusseldorf 17-20 November, we will be showcasing our unmatched capabilities in ultra-precise plastic injection molding, and why we are the go-to partner for next-generation medical device innovation.
With more than 80,000 participants and 750 exhibitors from over 165 countries, COMPAMED is the largest and most influential trade fair for suppliers to the medical manufacturing industry.
Operating from Stand #F20-5 in the US Pavilion, Hall 8b, we will highlight our 40+ years of pioneering experience in high-volume micro molding, supporting medical applications where precision and reliability are non-negotiable. Whether producing parts with micron-level tolerances, microfluidic channels, or components smaller than a grain of sand, Accumold has the infrastructure and know-how to deliver.
“We don’t just mold parts, we engineer solutions for the most demanding medical applications in the world,” said Petra Badrah, Business Development Manager Europe for Accumold. “Our customers know that success in medical device manufacturing isn’t about finding a vendor. It’s about finding a strategic partner who can collaborate from concept through scale. That’s where Accumold excels.”
As a vertically integrated operation, Accumold maintains in-house tooling, automation, metrology, and cleanroom molding to ensure consistency and quality across every project. From bioresorbable materials to high-temperature thermoplastics like PEEK and LCP, Accumold routinely molds what others deem impossible.
Attendees can also explore Accumold’s extensive Design for Micro Molding (DfMM) capabilities, which are critical for customers looking to reduce design iterations, improve manufacturability, and speed time to market.
To experience why Accumold is the trusted partner of leading OEMs across the globe, visit Stand #F20-5 at COMPAMED 2025 and discover how micro molding is enabling the next generation of medtech innovation.